MT1 effects on cell motility may be exerted through integrin activation, as MT1-mediated cleavage of the vitronectin receptor αvβ3 enhanced breast cancer cell motility on this substrate (Deryugina et al, 2002). Here, ITGAV is linked to breast carcinoma.